PT Jayamas Medica Industri Tbk(ID:OMED)
Rp169.00+1.00 (+0.60%)
ID:OMED
PT Jayamas Medica Industri Tbk financials statements
Rp169.00
At close:+1.00 (+0.60%)
PT Jayamas Medica Industri Tbk (OMED) Ratios
PT Jayamas Medica Industri Tbk Ratios
ID:OMED's free cash flow for Q3 2026 was Rp128.47B. For the 2026 fiscal year, ID:OMED's free cash flow was decreased by Rp-20.50B and operating cash flow was Rp148.96B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 10.36 | 7.66 | 15.04 | 9.15 | 5.46 |
| Quick Ratio | 6.96 | 5.49 | 10.34 | 6.72 | 3.84 |
| Cash Ratio | 5.43 | 4.15 | 8.23 | 3.60 | 2.69 |
| Solvency Ratio | 0.98 | 1.15 | 0.94 | 0.75 | 1.24 |
| Operating Cash Flow Ratio | 1.68 | 1.19 | 0.99 | 0.40 | 1.85 |
| Short-Term Operating Cash Flow Coverage | 117.42 | 2.20 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | Rp 1.99T | Rp 1.93T | Rp 1.71T | Rp 1.67T | Rp 1.01T |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.07 | 0.07 | 0.07 | 0.08 | 0.11 |
| Debt-to-Equity Ratio | 0.08 | 0.08 | 0.09 | 0.10 | 0.15 |
| Debt-to-Capital Ratio | 0.07 | 0.07 | 0.08 | 0.09 | 0.13 |
| Long-Term Debt-to-Capital Ratio | 0.06 | 0.00 | 0.07 | 0.07 | 0.12 |
| Financial Leverage Ratio | 1.18 | 1.15 | 1.16 | 1.23 | 1.41 |
| Debt Service Coverage Ratio | 17.48 | 2.24 | 17.34 | 17.08 | 28.92 |
| Interest Coverage Ratio | 21.61 | 17.80 | 15.59 | 18.35 | 33.83 |
| Debt to Market Cap | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 |
| Interest Debt Per Share | 8.65 | 7.58 | 7.71 | 8.14 | 7.70 |
| Net Debt to EBITDA | -2.32 | -2.20 | -2.32 | -1.45 | -0.69 |
| Profitability Margins | |||||
| Gross Profit Margin | 33.68% | 33.09% | 31.78% | 32.38% | 40.61% |
| EBIT Margin | 18.72% | 21.93% | 19.85% | 22.58% | 33.72% |
| EBITDA Margin | 22.16% | 25.05% | 23.13% | 24.98% | 35.33% |
| Operating Profit Margin | 18.72% | 18.48% | 17.42% | 21.79% | 32.99% |
| Pretax Profit Margin | 22.04% | 20.89% | 18.78% | 21.40% | 32.75% |
| Net Profit Margin | 17.78% | 17.06% | 14.93% | 16.43% | 25.27% |
| Continuous Operations Profit Margin | 17.88% | 17.18% | 15.02% | 16.70% | 25.62% |
| Net Income Per EBT | 80.66% | 81.64% | 79.52% | 76.80% | 77.17% |
| EBT Per EBIT | 117.74% | 113.07% | 107.80% | 98.20% | 99.28% |
| Return on Assets (ROA) | 11.47% | 11.39% | 10.05% | 11.40% | 32.59% |
| Return on Equity (ROE) | 13.49% | 13.07% | 11.69% | 13.98% | 45.96% |
| Return on Capital Employed (ROCE) | 13.04% | 13.77% | 12.37% | 16.65% | 50.53% |
| Return on Invested Capital (ROIC) | 10.46% | 10.60% | 9.85% | 12.88% | 39.11% |
| Return on Tangible Assets | 11.48% | 11.48% | 10.05% | 11.40% | 32.61% |
| Earnings Yield | 6.59% | 6.60% | 4.48% | 4.98% | 8.25% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.23 | 7.02 | 8.19 | 9.28 | 12.10 |
| Payables Turnover | 10.03 | 13.93 | 12.45 | 6.16 | 7.48 |
| Inventory Turnover | 1.71 | 1.97 | 1.85 | 2.10 | 2.98 |
| Fixed Asset Turnover | 3.85 | 4.19 | 4.57 | 6.23 | 9.86 |
| Asset Turnover | 0.65 | 0.67 | 0.67 | 0.69 | 1.29 |
| Working Capital Turnover Ratio | 0.99 | 0.97 | 0.92 | 1.12 | 2.01 |
| Cash Conversion Cycle | 227.35 | 210.89 | 212.48 | 154.03 | 103.95 |
| Days of Sales Outstanding | 50.49 | 51.98 | 44.58 | 39.34 | 30.16 |
| Days of Inventory Outstanding | 213.25 | 185.12 | 197.22 | 173.97 | 122.60 |
| Days of Payables Outstanding | 36.39 | 26.21 | 29.31 | 59.28 | 48.82 |
| Operating Cycle | 263.73 | 237.10 | 241.80 | 213.30 | 152.76 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 14.61 | 12.99 | 4.97 | 3.42 | 18.67 |
| Free Cash Flow Per Share | 10.32 | 9.21 | -0.82 | 0.64 | 15.61 |
| Dividend Paid and CapEx Coverage Ratio | 1.86 | 1.95 | 0.55 | 0.28 | 1.50 |
| Capital Expenditure Coverage Ratio | 3.41 | 3.44 | 0.86 | 1.23 | 6.10 |
| Operating Cash Flow Coverage Ratio | 1.83 | 1.89 | 0.71 | 0.46 | 2.71 |
| Operating Cash Flow to Sales Ratio | 0.19 | 0.19 | 0.08 | 0.05 | 0.23 |
| Free Cash Flow Yield | 5.01% | 5.12% | -0.38% | 0.30% | 6.19% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 15.18 | 15.14 | 22.31 | 20.08 | 12.12 |
| Price-to-Sales (P/S) Ratio | 2.70 | 2.58 | 3.33 | 3.30 | 3.06 |
| Price-to-Book (P/B) Ratio | 2.05 | 1.98 | 2.61 | 2.81 | 5.57 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 19.95 | 19.54 | -262.17 | 332.61 | 16.15 |
| Price-to-Operating Cash Flow Ratio | 14.10 | 13.85 | 43.10 | 61.94 | 13.50 |
| Price-to-Earnings Growth (PEG) Ratio | 1.07 | 0.63 | -2.43 | -0.41 | -0.68 |
| Enterprise Value Multiple | 9.86 | 8.11 | 12.09 | 11.75 | 7.97 |
| Enterprise Value | 4.51T | 3.83T | 4.86T | 5.11T | 6.27T |
| EV to EBITDA | 9.86 | 8.11 | 12.09 | 11.75 | 7.97 |
| EV to Sales | 2.18 | 2.03 | 2.80 | 2.94 | 2.82 |
| EV to Free Cash Flow | 16.15 | 15.37 | -220.00 | 296.03 | 14.85 |
| EV to Operating Cash Flow | 11.41 | 10.90 | 36.17 | 55.13 | 12.42 |
| Tangible Book Value Per Share | 101.80 | 91.36 | 82.98 | 76.46 | 46.00 |
| Shareholders’ Equity Per Share | 100.61 | 90.96 | 81.98 | 75.55 | 45.25 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.19 | 0.18 | 0.20 | 0.22 | 0.22 |
| Revenue Per Share | 76.32 | 69.69 | 64.19 | 64.27 | 82.29 |
| Net Income Per Share | 13.57 | 11.89 | 9.59 | 10.56 | 20.80 |
| Tax Burden | 0.81 | 0.82 | 0.80 | 0.77 | 0.77 |
| Interest Burden | 1.18 | 0.95 | 0.95 | 0.95 | 0.97 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.07 | 0.06 | 0.06 | 0.05 | 0.03 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.08 | 1.09 | 0.52 | 0.32 | 0.90 |
Currency in IDR
